CKD Study to Move Upstream by Embedding Pharmacists in Primary Care
Katherine Tuttle, M.D., executive director for research at Providence Inland Northwest Health, says new therapies…
Katherine Tuttle, M.D., executive director for research at Providence Inland Northwest Health, says new therapies provide opportunities for earlier interventions with high-risk patients
Major federal changes to Medicaid eligibility and financing from the 2025 reconciliation law are coming, including new work requirements that will affect millions of Medicaid enrollees. KFF’s fact sheet provides an overview of what has changed, what is still ahead, and what the public thinks about Medicaid heading into the midterms.
A patient’s automated risk score was reassuringly green. Pulling from a sparse medical record and infrequent acute visits, the model flagged him as low risk and routed him to the default, low-touch outpatient pathway — so why was the patient actively deteriorating? The post Your Product Works — So Why Does It Still Fail in…
While again pointing to pressures from the No Surprises Act arbitration process, the industry giant’s executives also say that care intensity trends are “bending in a more stable direction.”
Building on previous analysis of state directed payments (SDPs), this issue brief takes a closer look at SDPs for nursing home services.
LAVONIA, Ga. — It had been a decade since Kara Holden last had a baby. But as the former obstetric nurse prepared for her fourth child, her head was swimming with contingency plans. The labor and delivery unit where she used to work in this rural northeastern Georgia community is no longer open. So, she…
Four years ago, Oregon hospitals were under fire from state authorities and patient advocates. Hospitals, critics said, had made it too hard for patients to apply for and receive help paying their bills. Within months, the state enacted a sweeping law that required hospitals to proactively screen patients and give financial aid to those who…
By HANA KAHLEOVA “Will this only get worse?” Patients with type 2 diabetes have asked me some version of that question for my entire career. For most of it, the honest answer was “probably.” We treated diabetes as a one-way street: glucose climbs, medications pile up, complications follow. Good care slowed the slope. It didn’t…
Rick Abramson, a radiologist by training and the director of FDA’s Digital Health Center of Excellence said, “We ended up putting out this idea that maybe these devices are starting to behave a little bit more like me as a physician than a heart valve or a defibrillator.” The post FDA Official Believes GenAI-enabled Tools…
The Series A round was led by Define Ventures, with participation from Y Combinator and the California Health Care Foundation Innovation Fund. The post Readily Secures $11M for Compliance Intelligence Platform appeared first on MedCity News.